Table 2. Patient factors impact on device selection.

Patient factors	Preoperative considerations	Device selection
Limited manual dexterity (28,35)	(I) Difficulty with device inflation/deflation	(I) Malleable: (i) AMS Spectra; (ii) Coloplast Genesis (II) Pump: (i) AMS Momentary Squeeze; (ii) Coloplast Titan
Spinal cord injured (12,37)	(I) Limited upper extremity movement (II) Higher incidence of CIC/condom cath use (III) Higher risk of prosthesis complication (infection/erosion/malfunction)	Malleable: (i) AMS Spectra; (ii) Coloplast Genesis
Peyronie’s disease (28,30)	(I) Curvature exacerbated by length expansion (II) Benefit from modeling after device implantation	Three-piece IPP: (i) AMS 700 CX; (ii) Coloplast Titan
Prior pelvic surgery (35,46,47)	(I) Obliteration of the space of Retzius from robotic prostatectomy, laparoscopic hernia, or renal transplant (II) Consider ectopic reservoir placement	(I) Two-piece IPP: AMS Ambicor (II) Reservoirs: (i) AMS Conceal; (ii) Coloplast Cloverleaf
Corporal fibrosis (1,35,46)	(I) Increased risk of infection, corporal perforation, and urethral injury (II) Difficulty with corporal dilation	Narrow cylinder three-piece IPP: (i) AMS 700 CXR; (ii) Coloplast Titan Narrow
Prior explant or salvage (35,47)	(I) Increased risk of infection (II) If explanted, risk of fibrosis and penile shortening	(I) Malleable: (i) AMS Spectra; (ii) Coloplast Genesis (II) Coated implants: (i) AMS Inhibizone available on 700 series only; (ii) Coloplast hydrophilic coating available on Titan and Genesis